|
Volumn 43, Issue 5, 2011, Pages 1868-1870
|
Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
AZATHIOPRINE;
C REACTIVE PROTEIN;
CLEMASTINE;
COTRIMOXAZOLE;
CYCLOSPORIN;
PARACETAMOL;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
ADULT;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
ARTICLE;
BLOOD CELL COUNT;
BODY HEIGHT;
BODY WEIGHT;
BRONCHIOLITIS OBLITERANS;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE ASSOCIATION;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DYSPNEA;
EOSINOPHIL;
FEMALE;
HOSPITAL READMISSION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTERSTITIAL LUNG DISEASE;
INTERSTITIAL PNEUMONIA;
LEUKOCYTE COUNT;
LEUKOCYTOSIS;
LOW DRUG DOSE;
LUNG EMPHYSEMA;
LUNG FIBROSIS;
LUNG INFILTRATE;
LUNG TRANSPLANTATION;
OXYGEN SATURATION;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PULMONARY VASCULITIS;
SINGLE DRUG DOSE;
THORAX RADIOGRAPHY;
TRANSBRONCHIAL BIOPSY;
TREATMENT RESPONSE;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
LUNG DISEASES, INTERSTITIAL;
LUNG TRANSPLANTATION;
TREATMENT OUTCOME;
|
EID: 79959406090
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.02.007 Document Type: Article |
Times cited : (20)
|
References (4)
|